Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials

Fig. 1

Disease activity at baseline of clinical trials stratified by the presence or absence of rheumatoid factor (RF) or anti-citrullinated peptide antibodies (ACPAs). a Rituximab database (IMAGE trial of early RA). b Golimumab database (several trials on RA patients with various disease durations). Please see Table 2 for details on numbers and statistics. CDAI clinical disease activity index, DAS28-ESR Disease Activity Score using 28 joint counts-erythrocyte sedimentation rate, RA rheumatoid arthritis, SDAI simplified disease activity index

Back to article page